LPL Financial Portfolio holdings
LPL Financial, founded in 1989 through the merger of Linsco and Private Ledger and headquartered in San Diego, California, is the largest independent broker-dealer in the U.S., supporting over 22,000 financial advisors who manage more than $1.4 trillion in advisory and brokerage assets as of late 2024. Serving independent advisors, banks, and credit unions, LPL provides a robust technology platform, research, and back-office support, enabling advisors to offer personalized wealth management, retirement planning, and investment services to clients without proprietary products. The firm, publicly traded since 2010 under CEO Dan Arnold, has grown through acquisitions like Waddell & Reed’s wealth management business in 2021, emphasizing flexibility and advisor autonomy. With additional offices in Fort Mill, South Carolina, and Boston, LPL Financial remains a leader in empowering advisors amid a shifting financial landscape.
Top Buys
| 1 |
Capital Group Dividend Value ETF
CGDV
|
+$529M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$507M |
| 3 |
THRO
iShares U.S. Thematic Rotation Active ETF
THRO
|
+$494M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$485M |
| 5 |
NVIDIA
NVDA
|
+$404M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$787M |
| 2 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$365M |
| 3 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
+$97M |
| 4 |
Invesco Preferred ETF
PGX
|
+$92.7M |
| 5 |
Industrial Select Sector SPDR Fund
XLI
|
+$89.2M |
Sector Composition
| 1 | Technology | 8.5% |
| 2 | Financials | 3.73% |
| 3 | Consumer Discretionary | 2.77% |
| 4 | Communication Services | 2.41% |
| 5 | Industrials | 2.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3901
ImmunityBio
IBRX
$2.46B
| $809K | ﹤0.01% |
306,503
+111,357
| +57% | +$294K |
|
3902
Fox Class B
FOX
$23.5B
| $804K | ﹤0.01% |
15,581
+10,765
| +224% | +$556K |
|
3903
Extreme Networks
EXTR
$2.95B
| $804K | ﹤0.01% |
44,769
-997
| -2% | -$17.9K |
|
3904
Invesco Municipal Income Opportunities Trust
OIA
$288M
| $803K | ﹤0.01% |
139,733
+23,108
| +20% | +$133K |
|
|
BPMC
3905
DELISTED
Blueprint Medicines
BPMC
| $803K | ﹤0.01% |
6,261
-9,944
| -61% | -$1.27M |
|
|
ASM
3906
Avino Silver & Gold Mines
ASM
$640M
| $802K | ﹤0.01% |
222,795
+166,951
| +299% | +$601K |
|
3907
Union Bankshares
UNB
$118M
| $802K | ﹤0.01% |
30,116
-4,345
| -13% | -$116K |
|
3908
First Trust Eurozone AlphaDEX
FEUZ
$79.1M
| $801K | ﹤0.01% |
14,502
+2,184
| +18% | +$121K |
|
3909
UWM Holdings
UWMC
$1.5B
| $801K | ﹤0.01% |
193,442
-27,539
| -12% | -$114K |
|
3910
Runway Growth Finance
RWAY
$378M
| $800K | ﹤0.01% |
74,567
+43,190
| +138% | +$463K |
|
3911
RH Tactical Rotation ETF
RHRX
$16.4M
| $799K | ﹤0.01% |
47,967
+22,401
| +88% | +$373K |
|
|
LAC
3912
Lithium Americas
LAC
$691M
| $799K | ﹤0.01% |
298,117
-22,000
| -7% | -$59K |
|
3913
Cousins Properties
CUZ
$4.94B
| $799K | ﹤0.01% |
26,594
+2,045
| +8% | +$61.4K |
|
3914
Nuveen Churchill Direct Lending
NCDL
$758M
| $799K | ﹤0.01% |
49,325
+24,676
| +100% | +$400K |
|
3915
BlackRock Enhanced International Dividend Trust
BGY
$529M
| $795K | ﹤0.01% |
137,391
+2,824
| +2% | +$16.4K |
|
|
NAGE
3916
Niagen Bioscience, Inc. Common Stock
NAGE
$766M
| $795K | ﹤0.01% |
55,165
+25,469
| +86% | +$367K |
|
|
JHI
3917
John Hancock Investors Trust
JHI
$124M
| $795K | ﹤0.01% |
57,403
+8,811
| +18% | +$122K |
|
3918
Live Oak Bancshares
LOB
$1.67B
| $795K | ﹤0.01% |
26,669
+7,114
| +36% | +$212K |
|
3919
Petrobras Class A
PBR.A
$75.2B
| $794K | ﹤0.01% |
68,805
+12,900
| +23% | +$149K |
|
|
GMRE
3920
Global Medical REIT
GMRE
$512M
| $792K | ﹤0.01% |
114,314
+8,966
| +9% | +$62.1K |
|
3921
Brunswick
BC
$4.26B
| $792K | ﹤0.01% |
14,330
+2,754
| +24% | +$152K |
|
3922
AllianzIM U.S. Large Cap Buffer20 Nov ETF
NVBW
$73.7M
| $791K | ﹤0.01% |
24,551
+6,976
| +40% | +$225K |
|
3923
Cactus
WHD
$2.74B
| $791K | ﹤0.01% |
18,087
+4,415
| +32% | +$193K |
|
3924
VSE Corp
VSEC
$3.4B
| $790K | ﹤0.01% |
6,035
+944
| +19% | +$124K |
|
3925
Autoliv
ALV
$9.68B
| $789K | ﹤0.01% |
7,052
-3,522
| -33% | -$394K |
|